Stockreport

Alkermes Looks To FDA For Approval Of Schizophrenia Drug [Seeking Alpha]

Alkermes plc - Ordinary Shares  (ALKS) 
Last alkermes plc - ordinary shares earnings: 4/29 07:00 am Check Earnings Report
PDF Summary Alkermes achieved positive results from its second phase 3 study known as ENLIGHTEN-2, where those who took ALKS 3831 saw a reduction in weight gain comp [Read more]